![Gregory Demopulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Demopulos
Verkställande Direktör på
OMEROS CORPORATION
Förmögenhet: 14 M $ per 2026-06-30
Profil
Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, where the title held is Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OMEROS CORPORATION 2,03 % | 2026-07-22 | 1 469 308 ( 2,03 % ) | 14 M $ | 2026-06-30 |
Aktiva positioner av Gregory Demopulos
| Företag | Position | Start |
|---|---|---|
| OMEROS CORPORATION | Verkställande Direktör | 1994-06-16 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Direktör/Styrelseledamot | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Direktör/Styrelseledamot | - |
Smead Funds Trust
 Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Direktör/Styrelseledamot | - |
Northwest NeuroNeighborhood | Direktör/Styrelseledamot | - |
Gregory Demopuloss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
55
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Health Technology |
Smead Funds Trust
Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Electronic Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest NeuroNeighborhood |
